Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Drug-drug Interaction of Cannabidiol and Morphine in Recreational Opioid Users

NCT05143424 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT05143424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05143424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Drug-drug Interaction of Cannabidiol and Morphine in Recreational Opioid Users
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Unknown status
Start date
November 4, 2021
Completion date
December 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder